Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
P53 Pathway
100%
Bladder Cancer Risk
100%
SNP
100%
Genetic Variation
100%
Bladder Cancer
75%
TP63
75%
Arg72Pro
50%
Tumor
50%
Germline Variants
50%
SERPINB5
50%
Least Absolute Shrinkage and Selection Operator (LASSO)
50%
Classical Analysis
25%
Cancer Genetic Susceptibility
25%
BAK1
25%
Pma1
25%
Rs1042522
25%
TP73
25%
Common Variants
25%
Golden Gate
25%
Multiple Testing
25%
Penalized Logistic Regression
25%
Logistic Regression Analysis
25%
Pathways in Cancer
25%
Insulin-like Growth Factor 1 Receptor (IGF1R)
25%
Disease Subtypes
25%
Blood DNA
25%
Overall Risk
25%
Hospital Controls
25%
Newly Diagnosed
25%
TaqMan Assay
25%
Tag SNP
25%
Classical Test Theory
25%
P53 Expression
25%
Cancer Susceptibility
25%
Illumina
25%
Common SNP
25%
SNP Association
25%
Depth Assessment
25%
White Europeans
25%
Results-based
25%
Bladder Cancer Patients
25%
Biochemistry, Genetics and Molecular Biology
Single Nucleotide Polymorphism
100%
Genetic Variation
100%
Genetic Divergence
100%
TP63
50%
Germ Cell
33%
Germline
33%
Cancer Genetics
16%
Genetic Susceptibility
16%
TaqMan
16%
P53
16%
Common Variant
16%